Genmab A/S (GNMSF)
OTCMKTS · Delayed Price · Currency is USD
316.00
0.00 (0.00%)
Dec 9, 2025, 4:00 PM EST
Genmab Market Cap
Genmab has a market cap or net worth of $19.13 billion as of December 10, 2025. Its market cap has increased by 45.65% in one year.
Market Cap
19.13B
Enterprise Value
15.88B
Revenue
3.85B
Ranking
n/a
PE Ratio
12.08
Stock Price
$316.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 415.12M to 19.13B, an increase of 4,507.98%. That is a compound annual growth rate of 16.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 19.13B | 44.97% |
| Dec 30, 2024 | 13.19B | -36.79% |
| Dec 29, 2023 | 20.88B | -24.42% |
| Dec 30, 2022 | 27.62B | 5.40% |
| Dec 30, 2021 | 26.20B | -1.50% |
| Dec 30, 2020 | 26.60B | 83.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Elite Pharmaceuticals | 554.90M |
| Glass House Brands | 491.23M |
| CytoDyn | 415.92M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 364.04M |
| Silence Therapeutics | 326.39M |
| Nika Pharmaceuticals | 259.91M |